Financial Review: Waystar (NASDAQ:WAY) & Firefly Neuroscience (NASDAQ:AIFF)

Firefly Neuroscience (NASDAQ:AIFF) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, profitability and institutional ownership.

Profitability

This table compares Firefly Neuroscience and Waystar’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-565.40%	-94.68%	-73.51%
Waystar	11.18%	7.03%	4.75%

Risk and Volatility

Firefly Neuroscience has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, Waystar has a beta of 0.06, meaning that its stock price is 94% less volatile than the S&P 500.

Institutional and Insider Ownership

5.0% of Firefly Neuroscience shares are held by institutional investors. 6.9% of Firefly Neuroscience shares are held by company insiders. Comparatively, 3.5% of Waystar shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and target prices for Firefly Neuroscience and Waystar, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Firefly Neuroscience	1	0	0	0	1.00
Waystar	1	2	18	3	2.96

Waystar has a consensus target price of $35.14, suggesting a potential upside of 51.22%. Given Waystar’s stronger consensus rating and higher possible upside, analysts plainly believe Waystar is more favorable than Firefly Neuroscience.

Earnings & Valuation

This table compares Firefly Neuroscience and Waystar”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Firefly Neuroscience	$1.14 million	15.54	-$19.88 million	($0.63)	-1.80
Waystar	$1.10 billion	4.05	$112.09 million	$0.70	33.19

Waystar has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Summary

Waystar beats Firefly Neuroscience on 11 of the 15 factors compared between the two stocks.

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

About Waystar

Waystar Holding Corp. is a software company which provide healthcare payments. Waystar Holding Corp. is based in LEHI, Utah.